Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Film-coated tablet: 150 mg
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Erlotinib as as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
RiltaredErlotinib (as hydrochloride | 150 mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 30's) | Rx | Dr. Reddy's Laboratories Ltd. (Formulation FTO-7)India | Dr. Reddy's Laboratories Philippines Inc. | DR-XY48549 | Dec 29, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Erlotinib · Zydus Lifesciences Limited [US FDA-approved label, version 3, November 28, 2024]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=daaa1329-3a3f-439c-b13d-b301daa234d4
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .